Biora Therapeutics, Inc. Operating Income
Biora Therapeutics, Inc. reported Operating Income of -$16.23 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-11-14
- Biora Therapeutics, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$16.23M.
- Biora Therapeutics, Inc. operating income (loss) for the quarter ending 2024-06-30 was -$15.79M.
- Biora Therapeutics, Inc. operating income (loss) for the quarter ending 2024-03-31 was -$15.52M.
- Biora Therapeutics, Inc. operating income (loss) for the quarter ending 2023-12-31 was -$13.34M.
- Biora Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$67.14M.
- Biora Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$61.78M.
- Biora Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$117.84M.
- Biora Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$107.62M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$16.23M 10-Q · filed 2024-11-14 | -$32.01M derived: sum of 2 quarters · filed 2024-11-14 | -$47.53M 10-Q · filed 2024-11-14 | -$60.87M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-06-30 | -$15.79M 10-Q · filed 2024-08-12 | -$31.30M 10-Q · filed 2024-08-12 | -$44.65M derived: sum of 3 quarters · filed 2024-08-12 | -$67.97M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-03-31 | -$15.52M 10-Q · filed 2024-05-15 | -$28.86M derived: sum of 2 quarters · filed 2024-05-15 | -$52.18M derived: sum of 3 quarters · filed 2024-11-14 | -$67.11M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-12-31 | -$13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$36.66M derived: sum of 2 quarters · filed 2024-11-14 | -$51.60M derived: sum of 3 quarters · filed 2024-11-14 | -$67.14M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | -$23.32M 10-Q · filed 2024-11-14 | -$38.26M derived: sum of 2 quarters · filed 2024-11-14 | -$53.80M 10-Q · filed 2024-11-14 | -$67.58M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$14.93M 10-Q · filed 2024-08-12 | -$30.48M 10-Q · filed 2024-08-12 | -$44.25M derived: sum of 3 quarters · filed 2024-08-12 | -$58.14M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$15.54M 10-Q · filed 2024-05-15 | -$29.32M derived: sum of 2 quarters · filed 2024-05-15 | -$43.21M derived: sum of 3 quarters · filed 2024-05-15 | -$57.42M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$13.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$27.66M derived: sum of 2 quarters · filed 2024-04-01 | -$41.87M derived: sum of 3 quarters · filed 2024-04-01 | -$61.78M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$13.89M 10-Q · filed 2023-11-13 | -$28.10M derived: sum of 2 quarters · filed 2023-11-13 | -$48.01M 10-Q · filed 2023-11-13 | -$68.16M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$14.21M 10-Q · filed 2023-08-14 | -$34.12M 10-Q · filed 2023-08-14 | -$54.28M derived: sum of 3 quarters · filed 2023-08-14 | -$84.84M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$19.91M 10-Q · filed 2023-05-15 | -$40.07M derived: sum of 2 quarters · filed 2023-05-15 | -$70.63M derived: sum of 3 quarters · filed 2023-05-15 | -$106.28M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$20.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$50.72M derived: sum of 2 quarters · filed 2023-03-30 | -$86.37M derived: sum of 3 quarters · filed 2023-03-30 | -$117.84M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$30.56M 10-Q · filed 2022-11-14 | -$66.21M derived: sum of 2 quarters · filed 2022-11-14 | -$97.68M 10-Q · filed 2022-11-14 | -$149.05M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$35.65M 10-Q · filed 2022-08-15 | -$67.12M 10-Q · filed 2022-08-15 | -$118.49M derived: sum of 3 quarters · filed 2022-08-15 | -$149.15M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$31.46M 10-Q · filed 2022-05-10 | -$46.25M 10-Q · filed 2021-05-13 | -$82.83M derived: sum of 2 quarters · filed 2022-05-10 | -$113.50M derived: sum of 3 quarters · filed 2022-05-10 | -$139.98M derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | -$51.37M 10-K · filed 2021-03-18 | -$82.04M derived: sum of 2 quarters · filed 2021-11-10 | -$108.52M derived: sum of 3 quarters · filed 2021-11-10 | -$107.62M 10-K · filed 2022-03-28 | -$195.19M 10-K · filed 2021-03-18 | |||
| 2020-09-30 | -$30.67M 10-Q · filed 2021-11-10 | -$44.57M 10-Q · filed 2020-11-09 | -$57.15M derived: sum of 2 quarters · filed 2021-11-10 | -$81.80M 10-Q · filed 2021-11-10 | -$143.82M 10-Q · filed 2020-11-09 | -$158.65M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | -$26.48M 10-Q · filed 2021-08-12 | -$46.72M 10-Q · filed 2020-08-14 | -$51.13M 10-Q · filed 2021-08-12 | -$99.25M 10-Q · filed 2020-08-14 | -$127.98M derived: sum of 3 quarters · filed 2021-08-12 | -$182.82M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$52.53M 10-Q · filed 2021-05-13 | -$101.50M derived: sum of 2 quarters · filed 2021-05-13 | -$156.34M derived: sum of 3 quarters · filed 2021-05-13 | -$170.64M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$48.97M 10-K · filed 2021-03-18 | -$103.81M derived: sum of 2 quarters · filed 2021-03-18 | -$118.11M derived: sum of 3 quarters · filed 2021-03-18 | -$140.12M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$54.84M 10-K · filed 2021-03-18 | -$69.14M derived: sum of 2 quarters · filed 2021-03-18 | -$91.15M 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | -$14.30M 10-K · filed 2021-03-18 | -$36.30M 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | -$22.01M 10-K · filed 2021-03-18 |